Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

It usually takes more than a decade for a drug company to recoup the amount of money they put into the development of new medicines. For a drug company, it is a huge economical decision to choose ...

A team of chemists, biologists and microbiologists led by researchers in Arts & Sciences at Washington University in St.

Every few days, doctors needed to drain liters ... money to be made developing a new drug for a small number of patients, said Christine Colvis, who heads drug development partnership programs ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...

A groundbreaking type of artificial intelligence (AI) could speed up new drug development by around six ... “Patients with cancer need new treatment options as quickly as possible, so speeding ...

Once a promising drug has been identified in the lab, pharma firms need ... development chain, Pomberger said acceleration here can make a meaningful difference in shrinking the time it takes to ...

By contributor Jane Kirby, PA Health Editor Published Just now Scientists say a new AI method for looking at cells could speed up drug development ... with cancer need new treatment options ...

Every few days, doctors needed to drain liters of fluid ... There isn’t typically much money to be made developing a new drug ...